Cell cycle progression is governed by a higher tier of regulation implemented by tumor suppressor genes, whose protein products act as brakes rather than accelerators of division. p53 — termed the "guardian of the genome" — binds DNA directly to induce transcription of inhibitory proteins such as p21, which inhibits cyclin-dependent kinase (CDK) and thereby blocks CDK-driven initiation of DNA replication and entry into mitosis; RB functions in the same suppressive network. Because these proteins restrain division, the pathogenic mutation is loss of function rather than gain, so their defect releases cell cycle control and predisposes to cancer. The concept belongs to cell biology and molecular oncology, connecting CDK-based cycle machinery to tumor genetics and to the principle that division is licensed only when energetically and developmentally appropriate.
Cell cycle progression is governed by a higher tier of regulation implemented by tumor suppressor genes, whose protein products act as brakes rather than accelerators of division. p53 — termed the "g…